Accenture Invests, Through Accenture Ventures, In 1910 Genetics; Terms Not Disclosed
Accenture Invests, Through Accenture Ventures, In 1910 Genetics; Terms Not Disclosed
埃森哲通過埃森哲風投公司對1910 Genetics進行投資；具體條款未透露
As part of this investment, Accenture and 1910 will collaborate to combine tailored solutions and scalable infrastructure to help clients in the biopharma industry accelerate drug target identification, reduce costs, and deliver better, more affordable therapies to patients.
作爲這項投資的一部分，埃森哲和1910將合作，結合定製解決方案和可擴展的製造行業基礎設施，幫助客戶加快藥物靶標識別，降低成本，並向患者提供更好、更實惠的療法。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
資訊熱榜
更新時間